logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Substancerelated Disorders

    Medications for Substancerelated Disorders

    FiltersReset Filters
    4 results
    • hylenex recombinant

      (Hyaluronidase)
      Antares Pharma, Inc.
      Usage: HYLENEX recombinant is indicated for subcutaneous fluid administration to achieve hydration, as an adjuvant to enhance the dispersion and absorption of injected drugs, and in subcutaneous urography to improve the resorption of radiopaque agents.
    • sodium bicarbonate

      (sodium bicarbonate injection,)
      Long Grove Pharmaceuticals, LLC
      Usage: Sodium Bicarbonate Injection is indicated for treating metabolic acidosis in conditions like severe renal disease, uncontrolled diabetes, shock, cardiac arrest, and certain drug intoxications. It helps alkalinize urine in hemolytic reactions and counteracts bicarbonate loss in severe diarrhea, while addressing underlying causes when possible.
    • sodium bicarbonate

      (SODIUM BICARBONATE)
      Hospira, Inc.
      Usage: Sodium Bicarbonate Injection is indicated for treating metabolic acidosis resulting from severe renal disease, shock, diabetic acidosis, or lactic acidosis. It also helps in specific drug intoxications and severe diarrhea, aiding in urine alkalinization to reduce nephrotoxicity. Therapy should complement addressing the acidosis's underlying cause.
    • vitrase

      (hyaluronidase, ovine)
      Bausch & Lomb Incorporated
      Usage: VITRASE® (hyaluronidase injection) is indicated for enhancing hydration through subcutaneous fluid administration, increasing dispersion and absorption of injected drugs, and improving resorption of radiopaque agents in subcutaneous urography.